Inflammatory breast cancer: High risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer

Breast Cancer Research and Treatment

Volumn 129, Issue 1, 2011, Pages 117-124

  Schairer, Catherine ^a   Brown, Linda M ^b   Mai, Phuong L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Absolute risk; Contralateral breast cancer; Inflammatory breast cancer

Indexed keywords

HORMONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATORY BREAST CANCER; MAJOR CLINICAL STUDY; METASTASIS; NON INFLAMMATORY BREAST CANCER; PRIORITY JOURNAL; RECURRENT CANCER;

ADULT; AGE OF ONSET; AGED; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RISK; SEER PROGRAM;

EID: 79960842697     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1324-y     Document Type: Article

References (27)

1. Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH (2005-2006) Epidemiology of inflammatory breast cancer. Breast Dis 22:9-23
2. JL Bernstein RH Lapinski SS Thakore JT Doucette WD Thompson 2003 The descriptive epidemiology of second primary breast cancer Epidemiology 14 522 558 10.1097/01.ede.0000072105.39021.6d (Pubitemid 40417036)
3. A Berrington de Gonzalez RE Curtis E Gilbert CD Berg SA Smith M Stovall E Ron 2010 Second solid cancers after radiotherapy for breast cancer in SEER cancer registries Br J Cancer 102 220 226 19935795 10.1038/sj.bjc.6605435 1:STN:280:DC%2BC3c%2FgslWgsQ%3D%3D
4. AW Kurian LA McClure EM John PL Horn-Ross JM Ford CA Clarke 2009 Second primary breast cancer occurrence according to hormone receptor status J Natl Cancer Inst 101 1058 1065 19590058 10.1093/jnci/djp181 1:CAS:528: DC%2BD1MXpvF2qur4%3D
5. Bouchardy C, Benhamou S, Fioretta G, Verkooijen HM, Chappuis PO, Neyroud-Caspar I, Castiglione M, Vinh-Hung V, Vlastos G, Rapiti E (2010) Risk of second breast cancer according to estrogen receptor status and family history. Breast Cancer Res Treat. Published online: 29 September 2010
6. C Rubino R Arriagada S Delaloge MG Lê 2010 Relation of risk of contralateral breast cancer to the interval since the first primary tumor Br J Cancer 102 213 219 19920826 10.1038/sj.bjc.6605434 1:STN:280: DC%2BC3c%2FgslSktA%3D%3D
7. EN Imyanitov KP Hanson 2003 Molecular pathogenesis of bilateral breast cancer Cancer Lett 191 1 7 12609703 10.1016/S0304-3835(02)00523-2 1:CAS:528:DC%2BD3sXhsVCmu78%3D (Pubitemid 36254771)
8. Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr (eds) (2006) New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute, NIH Publ. No. 05-5302, Bethesda, MD
9. SM Swain JW Wilson EP Mamounas J Bryant D Wickerham B Fisher S Paik N Wolmark 2004 Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer J Natl Cancer Inst 96 516 523 15069113 10.1093/jnci/djh097 1:CAS:528:DC%2BD2cXjtVShtb4%3D (Pubitemid 38559575)
10. Banelli B, Casciano I, Di Vinci A, Gatteschi B, Levaggi A, Carli F, Bighin C, Salvi S, Allemanni G, Ghiorzo P, Pronzato P, Venturini M, Romani M, and Del Mastro L (2010) Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer. Ann Oncol 21:1237-1242
11. T Tuttle E Habermann A Abraham T Emory B Virnig 2007 Contralateral prophylactic mastectomy for patients with unilateral breast cancer Expert Rev Anticancer Ther 7 1117 1122 18028020 10.1586/14737140.7.8.1117 (Pubitemid 47365005)
12. Surveillance, Epidemiology, and End Results (SEER) Program ( www.seer.cancer.gov ) SEER Stat Database: incidence-SEER 9 Regs Limited-Use, Nov 2007 Sub (1973-2005) -Linked To County Attributes-Total U.S., 1969-2005 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Released April 2008, based on the November 2007 submission
13. Klein JP, Moeschberger ML (2003) Survival analysis: techniques for censored and truncated data. Springer Verlag, New York, pp 127-128
14. Software Citation: DevCan: Probability of Developing or Dying of Cancer Software, Version 6.5.0. Statistical Research and Applications Branch, National Cancer Institute, 2010. http://srab.cancer.gov/devcan
15. Online text is a revision of the text "Basic Human Anatomy" which was published in 1983 by W.B. Saunders. Copyright © O'Rahilly 2008 Author: Ronan O'Rahilly, MD. Site editor: Rand Swenson, DC, MD, PhD With: Fabiola Muller, Dr. rer. nat. and Stanley Carpenter, PhD Contributors: Brian Catlin, MD John Lyons, MD Dartmouth Medical School
16. S Van Laere T Beissbarth I Van Der Auwera G Van den Eynden XB Trinh H Elst P Van Hummelen P van Dam E Van Marck P Vermeulen L Dirix 2008 Relapse-free survival in breast cancer patients associated with a gene expression signature characteristic for inflammatory breast cancer Clin Cancer Res 14 7452 7460 19010862 10.1158/1078-0432.CCR-08-1077
17. M Cristofanilli V Valero AU Buzdar S-W Kau KR Broglio AM Gonzalez-Angulo N Sneige R Islam NT Ueno TA Buchholz SE Singletary GN Hortobagyi 2007 Inflammatory breast cancer (IBC) and patterns of recurrence Cancer 110 1436 1444 17694554 10.1002/cncr.22927 (Pubitemid 47463056)
18. IA Jaiyesimi AU Buzdar G Hortobagyi 1992 Inflammatory breast cancer: a review J Clin Oncol 10 1014 1024 1588366 1:STN:280:DyaK383mvV2gtQ%3D%3D
19. F Bertucci P Finetti D Birnbaum P Viens 2010 Gene expression profiling of inflammatory breast cancer Cancer 116 11 Suppl 2783 2793 20503410 10.1002/cncr.25165 1:CAS:528:DC%2BC3cXnvVahu7Y%3D
20. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22:515-523
21. S Dawood 2010 Biology and management of inflammatory breast cancer Expert Rev Anticancer Ther 10 209 220 20131997 10.1586/era.09.90 1:CAS:528: DC%2BC3cXhsFGit7Y%3D
22. EBCTCG (Early Breast Cancer Trialists' Collaborative Group) 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials Lancet 365 1687 1717 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
23. MK Graeser C Engel K Rhiem D Gadzicki U Bick K Kast UG Froster B Schlehe A Bechtold N Arnold S Preisler-Adams C Nestle-Kraemling M Zaino M Loeffler M Kiechle A Meindl D Varga RK Schmutzler 2009 Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers J Clin Oncol 27 5887 5892 19858402 10.1200/JCO.2008.19.9430
24. JA Largent M Capanu L Bernstein B Langholz L Mellemkjaer KE Malone CB Begg RW Haile CF Lynch H Anton-Culver A Wolitzer JL Bernstein 2007 Reproductive history and risk of second primary breast cancer: the WECARE Study Cancer Epidemiol Biomarkders Prev 16 906 911 10.1158/1055-9965.EPI-06-1003 (Pubitemid 46910090)
25. JC Figueiredo L Bernstein M Capanu KE Malone CF Lynch H Anton-Culver M Stovall L Bertelsen RW Haile JL Bernstein 2008 Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group J Clin Oncol 26 1411 1418 18250348 10.1200/JCO.2007.14.3081
26. WT Yang HT Le-Petross H Macapinlac S Carkaci AM Gonzalez-Angulo S Dawood E Resetkova GN Hortobagyi M Cristofanilli 2008 Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings Breast Cancer Res Treat 109 417 426 17653852 10.1007/s10549-007-9671-z 1:CAS:528:DC%2BD1cXlvVCgtr0%3D (Pubitemid 351692058)
27. Lostumbo L, Carbine NE, Wallace J, Ezzo J (2004) Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database of Systematic Reviews, Issue 4. Art. No. CD002748. doi: 10.1002/14651858.CD002748.pub2